Psychotic Disorders - India

India

Revenue in the Psychotic Disorders market is projected to reach €173.90m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.62%, resulting in a market volume of €179.40m by 2029.
In global comparison, most revenue will be generated in the United States (€2,093.00m in 2024).
In relation to total population figures, per person revenues of €18.55 are generated in 2024.

Key regions: Japan, Australia, Europe, India, France

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Psychotic Disorders market in India is experiencing significant growth and development, driven by various factors including customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Psychotic Disorders market in India are shifting towards more accessible and affordable treatment options. With an increasing awareness about mental health and the importance of early intervention, customers are seeking out therapies and medications that are effective and easily accessible. This has led to a rise in demand for antipsychotic medications and psychological therapies that can be easily accessed through clinics, hospitals, and online platforms.Trends in the market indicate a growing emphasis on holistic approaches to treating Psychotic Disorders in India. Traditional Indian medicine systems such as Ayurveda and Yoga are being integrated with modern psychiatric treatments to provide a comprehensive approach to mental health. This trend is driven by the belief that a combination of conventional medicine and alternative therapies can lead to better outcomes for patients. As a result, there is an increasing demand for Ayurvedic medicines, yoga therapy, and meditation techniques in the treatment of Psychotic Disorders.Local special circumstances in India also contribute to the development of the Psychotic Disorders market. India has a large population with a high prevalence of mental health disorders, including Psychotic Disorders. This creates a significant demand for psychiatric services and treatments. However, there is a shortage of mental healthcare professionals in the country, leading to long waiting times and limited access to quality care. This has prompted the development of innovative solutions such as telepsychiatry, where patients can receive consultations and therapy sessions remotely, bridging the gap between supply and demand.Underlying macroeconomic factors also play a role in the development of the Psychotic Disorders market in India. The country's rapid economic growth has led to an increase in disposable income and improved healthcare infrastructure. This has resulted in a greater ability and willingness to spend on mental healthcare services and treatments. Additionally, the government has recognized the importance of mental health and has taken steps to improve access to care and reduce the stigma associated with mental illnesses. These factors have created a conducive environment for the growth of the Psychotic Disorders market in India.In conclusion, the Psychotic Disorders market in India is experiencing significant growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards more accessible and holistic treatments, the high prevalence of mental health disorders, the shortage of mental healthcare professionals, and the country's rapid economic growth are all contributing to the expansion of the market. As the demand for mental healthcare services continues to rise, it is expected that the Psychotic Disorders market in India will continue to grow in the coming years.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.